Filtros de búsqueda

Lista de obras de

Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab

artículo científico publicado en 2017

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

artículo científico publicado en 2020

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

artículo científico publicado en 2015

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

artículo científico publicado en 2016

Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies.

artículo científico publicado en 2017

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.

artículo científico publicado en 2018

Clinical significance of signs of autoimmune colitis in 18F-fluorodeoxyglucose positron emission tomography-computed tomography of 100 stage-IV melanoma patients

scientific article published on 01 June 2019

Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions

artículo científico publicado en 2017

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

scientific article published on 13 November 2019

Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy

artículo científico publicado en 2016

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis

scientific article published on 26 February 2019

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

artículo científico publicado en 2020

Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab

scientific article published on 17 September 2020

Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients

artículo científico publicado en 2020

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.

artículo científico publicado en 2015

Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT

scientific article published on 05 June 2018

Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma

artículo científico publicado en 2016

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD-1-Antikörper beim metastasierten Melanom - ein Update

artículo científico publicado en 2020

Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD1-Antikörper beim metastasierten Melanom

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

scientific article published on 21 November 2020

Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma

scientific article published on 13 January 2020

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

artículo científico publicado en 2017

Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma.

artículo científico publicado en 2017

Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data

scientific article published on 31 October 2018

Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update

scientific article published on 03 June 2020

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

artículo científico publicado en 2016

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations

artículo científico publicado en 2019

The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma

artículo científico publicado en 2013

The outcome of ex vivo TIL expansion is highly influenced by spatial heterogeneity of the tumor T-cell repertoire and differences in intrinsic in vitro growth capacity between T-cell clones

scientific article published on 17 April 2020

The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma.

artículo científico publicado en 2018

Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management. ⬇️

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda